A cancer scientist, a chemist, and a biomedical engineer at the University of Rochester and its Wilmot Cancer Institute discovered a potential new drug and a new way to deliver it directly to acute myeloid leukemia cells.
Splitting immunotoxins in half could increase their specificity toward cancers, study suggests
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was diagnosed in late December. She died in January.